Pricing Log in Create free account

MDxHealth SA (MDXH) vs XWELL, Inc. (XWEL)

MDxHealth SA and XWELL, Inc. are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $6.1M — 2.4× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −7.58%. MDxHealth SA has the higher net margin (−32.5% vs −117.8%) and the lower return on invested capital (−23.8% vs 0.00%). Across the 17 metrics below, MDxHealth SA leads on 14 and XWELL, Inc. on 3.

Valuation

Metric MDXH XWEL Diagnostics & Research median
P/E n/m n/m 34.52
P/S 0.07 0.17 4.24
P/B n/m 0.59 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.12 23.44
EV/Sales 0.81 (0.06) 5.18
Earnings yield (480.00%) (933.33%) (1.50%)
Free cash flow yield (88.89%) (278.57%) 0.00%

Profitability

Metric MDXH XWEL Diagnostics & Research median
Gross margin 63.23% 34.34% 48.32%
Operating margin (18.04%) (61.31%) (5.68%)
Net margin (32.53%) (117.83%) (4.10%)
Free cash flow margin (5.24%) (47.65%) 0.00%
Return on equity 238.67% (557.21%) 0.00%
Return on assets (27.38%) (155.10%) (6.05%)
Return on invested capital (23.77%) 0.00% 0.00%

Growth

Metric MDXH XWEL Diagnostics & Research median
Revenue growth (TTM) 21.46% (7.58%) 8.99%
EPS growth (last fiscal year) 42.24% (38.80%) 20.36%
Revenue growth, 5-year CAGR 42.34% 28.35% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXH XWEL Diagnostics & Research median
Debt to equity (3.42) 0.00 0.01
Current ratio 1.15 2.27 2.27
Net debt to EBITDA (10.71) (0.08) 0.68

Dividend

Metric MDXH XWEL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric MDXH XWEL Diagnostics & Research median
Market cap 14.40m 6.08m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack